Skip to main content
. 2026 Feb 28;38(1):39–51. doi: 10.21147/j.issn.1000-9604.2026.01.03

Table 2. Best therapeutic response evaluation.

Best response n (%)
Total (N=242) First-line (N=132) Second-line (N=110)
CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; ORR, objective response rate; DCR, disease control rate; 95% CI, 95% confidence interval.
CR 3 (1.2) 2 (1.5) 1 (0.9)
PR 84 (34.7) 48 (36.4) 36 (32.7)
SD 150 (62.0) 80 (60.6) 70 (63.6)
PD 5 (2.1) 2 (1.5) 3 (2.7)
ORR [% (95% CI)] 36.0 (30.2−42.2) 37.9 (30.0−46.4) 33.6 (25.5−42.9)
DCR [% (95% CI)] 97.9 (95.3−99.1) 98.5 (94.6−99.6) 97.3 (92.3−99.1)